Cover Image
市場調查報告書

全球內分泌檢查市場 - 產業分析·市場規模·佔有率·成長·趨勢·預測 (2015-2023年)

Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023

出版商 Transparency Market Research 商品編碼 352913
出版日期 內容資訊 英文 138 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球內分泌檢查市場 - 產業分析·市場規模·佔有率·成長·趨勢·預測 (2015-2023年) Endocrine Testing Market - Global Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023
出版日期: 2016年01月19日 內容資訊: 英文 138 Pages
簡介

全球內分泌檢查市場主要檢查別分為雌激素 (E2) 、黃體刺激素 (FSH) 、人類絨毛膜性腺激素 (hCG) 、促黃體生成素 (LH) 、脫氫異雄固酮-硫酸鹽(DHEAS) 、孕酮,睪固酮,甲狀腺刺激素 (TSH) 、催乳激素 (黃體刺激荷爾蒙) 、皮質醇及胰島素等檢查,診斷技術別則可分為串聯式質譜分析,免疫檢測,單株抗體 (單克隆) 及多克隆抗體,感測器,以及臨床化學技術。今後市場在全球性糖尿病患者及肥胖人口的增加與全球性老年人口的擴大等下預測將成長,同時高技術成本及新興經濟上健康意識的不足等,則有可能成為阻礙成長的要素。

本報告提供全球內分泌檢查市場現況與展望調查分析,提供您市場估計實際成果及預測,市場推動與阻礙成長要素分析,彙整主要檢查別·診斷技術別·各終端用戶·各地區的市場分析,以及主要企業簡介。

第1章 序

  • 調查的說明
  • 市場區隔
  • 調查手法
  • 前提條件

第2章 摘要整理

第3章 產業分析

  • 簡介
  • 市場動態
    • 推動市場成長要素
      • 全球性糖尿病患者及肥胖人口的增加
      • 全球性老年人口的擴大
      • 技術發展
    • 阻礙市場成長要素
      • 高技術成本
      • 新興經濟上健康意識的不足
    • 市場機會
      • 投資機會
    • 內分泌檢查市場:波特的五力分析
    • 市場魅力分析 - 內分泌檢查市場,各地區,2014年
    • 競爭情形
      • 全球內分泌檢查市場:市場佔有率,各主要企業
      • 家庭及診療所的內分泌檢查市場銷售額,實驗別

第4章 市場區隔 - 檢查別

  • 簡介
  • 全球雌激素 (E2) 檢驗市場銷售額
  • 全球黃體刺激素 (FSH) 檢驗市場銷售額
  • 全球人類絨毛膜性腺激素 (hCG) 檢驗市場銷售額
  • 全球促黃體生成素 (LH) 檢驗市場銷售額
  • 全球脫氫異雄固酮-硫酸鹽(DHEAS) 檢驗市場銷售額
  • 全球孕酮檢驗市場銷售額
  • 全球睪固酮檢驗市場銷售額
  • 全球甲狀腺刺激素 (TSH) 檢驗市場銷售額
  • 全球催乳激素 (黃體刺激荷爾蒙) 檢驗市場銷售額
  • 全球皮質醇檢驗市場銷售額
  • 全球胰島素檢驗市場銷售額
  • 全球及其他內分泌檢查市場銷售額

第5章 市場區隔 - 診斷技術別

  • 全球串聯式質譜分析市場銷售額
  • 全球免疫檢測技術市場銷售額
  • 全球單株抗體 (單克隆) 及多克隆抗體市場銷售額
  • 全球感應技術市場銷售額
  • 全球臨床化學技術市場銷售額
  • 全球及其他技術市場銷售額

第6章 市場區隔 - 各終端用戶

  • 全球醫院市場銷售額
  • 全球民間研究所市場銷售額
  • 全球門診病人診療中心市場銷售額
  • 全球居家檢查市場銷售額
  • 全球診療所市場銷售額

第7章 市場區隔 - 各地區

  • 北美市場銷售額
  • 歐洲市場銷售額
  • 亞太地區市場銷售額
  • 其他地區市場銷售額

第8章 建議

第9章 企業簡介

  • Abbott Laboratories
  • AB Sciex Pte. Ltd.
  • Agilent Technologies
  • Biomedical Diagnostics
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Siemens Healthcare GmbH (Siemens AG)
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
目錄

The global endocrine testing market has been broadly segmented on the basis of selected tests, diagnostic technologies, end-users, and geography. This report studies the current scenario as well as future market potential for endocrine testing globally. This report comprises an elaborate executive summary, which includes a market snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global endocrine testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter's Five Forces analysis, and market share analysis by key players (%) operating in the endocrine testing market.

Based on test, the global endocrine testing market has been segmented into estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each type has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on diagnostic technology, the global endocrine testing market has been segmented into five major technologies such as: tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor, and clinical chemistry technologies. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the tissue engineered skin substitutes market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

The end user segmentation elucidates the global endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices. The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each product (category) has been provided for the period from 2013 to 2023. The report on the endocrine testing market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global endocrine testing market has been categorized into North America, Europe, Asia Pacific, and Rest of the World. The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the endocrine testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include F-Hoffmann La Roche, Ltd., Abbott Laboratories, DiaSorin, Agilent Technologies, Siemens Healthcare, Thermo Fisher Scientific, AB SCIEX LLC, Bio Rad Laboratories, Lab Corporation, bioMerieux, Sysmex Corporation, Ortho-clinical Diagnostics, Quest Diagnostics and Biomedical Diagnostics.

The global endocrine testing market is segmented as follows:

Global Endocrine Testing Market, by Test, 2013-2023 (USD Million)

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others (Gastrin, Thymosin, Secretin, etc.)

Global Endocrine Testing Market, by Diagnostic Technology, 2013 - 2023 (USD Million)

  • Tandem Mass spectrometry
  • Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
  • Monoclonal and Polyclonal Antibody Technologies
  • Sensor (Electrochemical, Biosensors, etc.) Technologies
  • Clinical Chemistry Technologies
  • Others (Liquid Chromatography + Mass Spectrometry (LC-MS)

Global Endocrine Testing Market, by End User, 2013 - 2023 (USD Million)

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Home Based Tests
  • Physician Offices

Global Endocrine Testing Market, by Geography, 2013 - 2023 (USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 Assumptions

Chapter 2 Executive Summary

  • 2.1 Global Endocrine Testing Market Revenue, by Diagnostic Technologies, 2014 & 2023 (Value %)
  • 2.2 Global Endocrine Testing Market Revenue, by End-User, 2014 & 2023 (US$ Million)
  • 2.3 Global Endocrine Testing Market Revenue, by Tests, 2014 (US$ Million)
  • 2.4 Global Endocrine Testing Market Revenue, by Geography, 2014 & 2023 (US$ Million)
  • 2.5 Global Endocrine Testing Market, 2014 & 2023: Market Snapshot

Chapter 3 Industry Analysis

  • 3.1 Introduction
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
      • 3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
      • 3.2.1.2 Consistent rise in geriatric population Worldwide
      • 3.2.1.3 Technological advancements
    • 3.2.2 Restraints
      • 3.2.2.1 High cost of technology
      • 3.2.2.2 Lack of healthcare awareness in emerging economies
    • 3.2.3 Opportunity
      • 3.2.3.1 Investment Opportunity
    • 3.2.4 Endocrine Testing Market: Porter's Five Forces Analysis
    • 3.2.5 Market Attractiveness Analysis - Endocrine Testing Market, by Geography, 2014
    • 3.2.6 Competitive Landscape
      • 3.2.6.1 Global Endocrine Testing Market: Market Share, by Key Players, 2014 (%)
      • 3.2.6.2 At Home and Physician Office Endocrine Tests Market Revenue, by Tests, 2014 (US$ Million)

Chapter 4 Market Segmentation - By Tests

  • 4.1 Introduction
  • 4.2 Global Estradiol (E2) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.3 Global Follicle Stimulating Hormone (FSH) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.4 Global Human Chorionic Gonadotropin (hCG) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.5 Global Luteinizing Hormone (LH) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.6 Global Dehydroepiandrosterone sulfate (DHEAS) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.7 Global Progesterone Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.8 Global Testosterone Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.9 Global Thyroid Stimulating Hormone (TSH) Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.10 Global Prolactin Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.11 Global Cortisol Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.12 Global Insulin Test Market Revenue, 2013-2023 (US$ Mn)
  • 4.13 Global Other Endocrine Tests Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 Market Segmentation - By Diagnostic Technology

  • 5.1 Global Tandem Mass Spectrometry Market Revenue, 2013-2023 (US$ Mn)
  • 5.2 Global Immunoassay Technologies Market Revenue, 2013-2023 (US$ Mn)
  • 5.3 Global Monoclonal and Polyclonal Antibody Technologies Market Revenue, 2013-2023 (US$ Mn)
  • 5.4 Global Sensor Technologies Market Revenue, 2013-2023 (US$ Mn)
  • 5.5 Global Clinical Chemistry Technologies Market Revenue, 2013-2023 (US$ Mn)
  • 5.6 Global Others Technologies Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 Market Segmentation - By End User

  • 6.1 Global Hospitals Market Revenue, 2013-2023 (US$ Mn)
  • 6.2 Global Commercial Laboratories Market Revenue, 2013-2023 (US$ Mn)
  • 6.3 Global Ambulatory Care Centers Market Revenue, 2013-2023 (US$ Mn)
  • 6.4 Global Home Based tests Market Revenue, 2013-2023 (US$ Mn)
  • 6.5 Global Physician Offices Market Revenue, 2013-2023 (US$ Mn)

Chapter 7 Market Segmentation - By Geography

  • 7.1 Global North America Market Revenue, 2013-2023 (US$ Mn)
  • 7.2 Global Europe Market Revenue, 2013-2023 (US$ Mn)
  • 7.3 Global Asia Pacific Market Revenue, 2013-2023 (US$ Mn)
  • 7.4 Global Rest of the World Market Revenue, 2013-2023 (US$ Mn)

Chapter 8 Recommendations

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 AB Sciex Pte. Ltd.
  • 9.3 Agilent Technologies
  • 9.4 Biomedical Diagnostics
  • 9.5 bioMerieux SA
  • 9.6 Bio-Rad Laboratories, Inc.
  • 9.7 DiaSorin S.p.A.
  • 9.8 F. Hoffmann-La Roche Ltd.
  • 9.9 Laboratory Corporation of America Holdings (LabCorp)
  • 9.10 Ortho-Clinical Diagnostics
  • 9.11 Quest Diagnostics
  • 9.12 Siemens Healthcare GmbH (Siemens AG)
  • 9.13 Sysmex Corporation
  • 9.14 Thermo Fisher Scientific, Inc.
Back to Top